STOCK TITAN

IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

IQVIA Holdings Inc. (NYSE:IQV) has announced that Ron Bruehlman, the executive vice president and chief financial officer, will present at the Barclays Global Healthcare Conference in Miami, FL on Wednesday, March 15, 2023, at 9:30 a.m. ET. A live audio webcast of the presentation will be accessible via the IQVIA Investor Relations website, with a replay available later the same day. IQVIA is recognized for its advanced analytics, technology solutions, and clinical research services, operating in over 100 countries and employing approximately 86,000 individuals.

Positive
  • None.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays Global Healthcare Conference in Miami, FL on Wednesday, March 15, 2023 at 9:30 a.m. ET.

A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

IQVIAFIN

Nick Childs, IQVIA Investor Relations (nicholas.childs@iqvia.com)

+1.973.316.3828

Source: IQVIA

FAQ

When will Ron Bruehlman speak at the Barclays Global Healthcare Conference?

Ron Bruehlman will speak at the Barclays Global Healthcare Conference on March 15, 2023, at 9:30 a.m. ET.

How can I access the live webcast of the IQVIA conference presentation?

The live audio webcast can be accessed on the IQVIA Investor Relations website.

What is the role of Ron Bruehlman at IQVIA?

Ron Bruehlman serves as the executive vice president and chief financial officer at IQVIA.

What products and services does IQVIA provide?

IQVIA offers advanced analytics, technology solutions, and clinical research services to the life sciences industry.

How many employees does IQVIA have?

IQVIA employs approximately 86,000 individuals worldwide.

IQVIA Holdings Inc.

NYSE:IQV

IQV Rankings

IQV Latest News

IQV Stock Data

35.96B
179.82M
0.92%
94.4%
1.44%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States of America
DURHAM